Additionally, oncogenic signaling and cancer hallmarks were further aggravated in high-risk patients, such as epithelial-mesenchymal transition (EMT), glycolysis, angiogenesis, DNA repair, TGFβ signaling, mTORC1 signaling, MYC and E2F targets (Fig. 4j). The gene discussed is TGFB1; the disease is cancer.